Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 

 

Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Aug 31, 2023

Priyanka Dutta-Passecker is the CEO and Founder of Healiva, a Swiss start-up focused on innovative treatments for acute and chronic wounds. Healiva begins the process by cleaning the wound using an enzyme invented by Priyanka.  Depending on the severity of the wound, autologous or allogeneic cell therapy is used to make new skin to heal the wound.

Priyanka explains, "So, to give a background for when we talk about personalized cell therapies and autologous cell therapy. We take a patient here, and from the patient, we make the patient's skin. That means that we're completely personalizing and making the skin of the patient. And this is given to extremely chronic non-healing wound patients like venous leg ulcer patients or diabetic foot ulcer patients. The skin gets integrated on their ulcer and closes the ulcer. That's one of our autologous cell therapy products called Epidex."

"We do keep the primary cells when we take the hair follicle. As you may know, hair follicles are epithelial cells that we expand, and we keep the cells. And when they come back, we can make the full skin, the epidermis differentiation, within two weeks. But generally, it takes four weeks. And it's given to the patient once it's ready within four to five days."

"So, just to elaborate on what we mean by allogeneic cell therapy. So quite different from the autologous one, in allogenic cell therapy, we are taking healthy skin cells from you and me. We expand the skin cells, and we give the skin cells to the patient. What happens is that it releases growth factors which help in the healing. And there is no rejection because, of course, the cells do not stay on the wounds of the patient."

#Healiva #WoundCare #PatientCare #SwissStartups #CellTherapy #ChronicWounds #RegenerativeMedicine #Diabetes #Healthtech

healiva.com

Listen to the podcast here

Healiva